JP2022553329A5 - - Google Patents
Info
- Publication number
- JP2022553329A5 JP2022553329A5 JP2022523595A JP2022523595A JP2022553329A5 JP 2022553329 A5 JP2022553329 A5 JP 2022553329A5 JP 2022523595 A JP2022523595 A JP 2022523595A JP 2022523595 A JP2022523595 A JP 2022523595A JP 2022553329 A5 JP2022553329 A5 JP 2022553329A5
- Authority
- JP
- Japan
- Prior art keywords
- human subject
- tau
- antibody
- alzheimer
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025181171A JP2026012271A (ja) | 2019-10-22 | 2025-10-27 | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924633P | 2019-10-22 | 2019-10-22 | |
| US62/924,633 | 2019-10-22 | ||
| PCT/US2020/056676 WO2021081101A1 (en) | 2019-10-22 | 2020-10-21 | Anti-beta-amyloid antibody for treating alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025181171A Division JP2026012271A (ja) | 2019-10-22 | 2025-10-27 | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553329A JP2022553329A (ja) | 2022-12-22 |
| JP2022553329A5 true JP2022553329A5 (https=) | 2023-10-30 |
Family
ID=73344157
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523595A Pending JP2022553329A (ja) | 2019-10-22 | 2020-10-21 | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 |
| JP2025181171A Pending JP2026012271A (ja) | 2019-10-22 | 2025-10-27 | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025181171A Pending JP2026012271A (ja) | 2019-10-22 | 2025-10-27 | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220372123A1 (https=) |
| EP (1) | EP4048695A1 (https=) |
| JP (2) | JP2022553329A (https=) |
| KR (1) | KR20220084095A (https=) |
| CN (1) | CN114599393A (https=) |
| AU (1) | AU2020371612A1 (https=) |
| BR (1) | BR112022007595A2 (https=) |
| CA (1) | CA3158513A1 (https=) |
| CO (1) | CO2022004902A2 (https=) |
| IL (1) | IL292363A (https=) |
| JO (1) | JOP20220092A1 (https=) |
| MX (1) | MX2022004678A (https=) |
| WO (1) | WO2021081101A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2019152706A1 (en) | 2018-01-31 | 2019-08-08 | Alector Llc | Anti-ms4a6a antibodies and methods of use thereof |
| US11472874B2 (en) | 2018-01-31 | 2022-10-18 | Alector Llc | Anti-MS4A4A antibodies and methods of use thereof |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| TW202300517A (zh) * | 2021-03-12 | 2023-01-01 | 美商美國禮來大藥廠 | 抗類澱粉β抗體及其用途 |
| TW202300518A (zh) * | 2021-03-12 | 2023-01-01 | 美商美國禮來大藥廠 | 抗N3pGlu類澱粉β抗體及其用途 |
| WO2023081194A2 (en) * | 2021-11-03 | 2023-05-11 | Biogen Ma Inc. | Methods for treating alzheimer's disease |
| AU2022439338A1 (en) * | 2022-02-02 | 2024-08-15 | Eisai R&D Management Co., Ltd. | Methods of treatment using p-tau181 level |
| WO2024086796A1 (en) * | 2022-10-20 | 2024-04-25 | Alector Llc | Anti-ms4a4a antibodies with amyloid-beta therapies |
| US20240207362A1 (en) * | 2022-10-25 | 2024-06-27 | Institute For Basic Science (Ibs) | Extracranial Methods For Facilitating Cerebrospinal Fluid Drainage |
| EP4455161A1 (en) | 2023-04-24 | 2024-10-30 | ONO Pharmaceutical Co., Ltd. | Human-derived anti-collapsin response mediator protein 2 (crmp2) antibodies |
| TW202530246A (zh) | 2023-09-15 | 2025-08-01 | 愛爾蘭商歐賽爾普羅希那有限公司 | 細胞穿透劑及其用途 |
| WO2025117721A1 (en) * | 2023-11-27 | 2025-06-05 | Massachusetts Institute Of Technology | Reconstituted lipoprotein particles to rescue lipid defects in the alzheimer's brain |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008081008A1 (en) | 2007-01-05 | 2008-07-10 | University Of Zurich | Method of providing disease-specific binding molecules and targets |
| WO2008141321A1 (en) * | 2007-05-14 | 2008-11-20 | Medtronic, Inc. | Methods and device to neutralize soluble toxic agents in the brain |
| JO3076B1 (ar) * | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| EP2598882B1 (en) * | 2010-07-30 | 2017-07-26 | AC Immune S.A. | Safe and functional humanized antibodies for use in treating an amyloidosis |
| ME03008B (me) * | 2011-09-19 | 2018-10-20 | Axon Neuroscience Se | Terapija na osnovu proteina i dijagnoza patologije u којој posreduje tau u alcнajмerovoj bolesti |
| US20150315267A1 (en) * | 2012-12-07 | 2015-11-05 | Thierry Bussiere | A method of reducing brain amyloid plaques using anti-ab antibodies |
| MA41115A (fr) * | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
| CN114796481A (zh) * | 2016-06-07 | 2022-07-29 | 生物基因国际神经科学有限责任公司 | 治疗阿尔茨海默病的方法 |
-
2020
- 2020-10-21 KR KR1020227015913A patent/KR20220084095A/ko active Pending
- 2020-10-21 AU AU2020371612A patent/AU2020371612A1/en active Pending
- 2020-10-21 US US17/770,997 patent/US20220372123A1/en active Pending
- 2020-10-21 CA CA3158513A patent/CA3158513A1/en active Pending
- 2020-10-21 CN CN202080073830.0A patent/CN114599393A/zh active Pending
- 2020-10-21 IL IL292363A patent/IL292363A/en unknown
- 2020-10-21 EP EP20804740.7A patent/EP4048695A1/en active Pending
- 2020-10-21 JP JP2022523595A patent/JP2022553329A/ja active Pending
- 2020-10-21 BR BR112022007595A patent/BR112022007595A2/pt unknown
- 2020-10-21 MX MX2022004678A patent/MX2022004678A/es unknown
- 2020-10-21 WO PCT/US2020/056676 patent/WO2021081101A1/en not_active Ceased
-
2022
- 2022-04-19 CO CONC2022/0004902A patent/CO2022004902A2/es unknown
- 2022-04-20 JO JOP/2022/0092A patent/JOP20220092A1/ar unknown
-
2025
- 2025-10-27 JP JP2025181171A patent/JP2026012271A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553329A5 (https=) | ||
| JP2023011002A (ja) | アルツハイマー病の治療法 | |
| JP2026012271A (ja) | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 | |
| US8722042B2 (en) | Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease | |
| JP2023520516A5 (https=) | ||
| JP7319421B2 (ja) | アルツハイマー病を治療するための抗ａベータプロトフィブリル抗体及びベータ－セクレターゼｂａｃｅ１阻害剤を含む組成物 | |
| JP7792428B2 (ja) | 抗アミロイドベータ抗体及びその使用 | |
| JP2025131566A5 (https=) | ||
| AU2019306477A1 (en) | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products | |
| JP2024540294A5 (https=) | ||
| JP2025530190A (ja) | アルツハイマー病治療のための免疫療法薬とｓｃｙｌｌｏ－イノシトールとの組み合わせ | |
| Pavlakis et al. | Magnetic resonance spectroscopy in childhood AIDS encephalopathy | |
| JP2024540294A (ja) | アルツハイマー病を治療するための方法 | |
| Faerber et al. | Cerebral MR of Menkes kinky-hair disease | |
| JP2023549075A5 (https=) | ||
| Kes et al. | Therapeutic Plasma Exchange in the Neurologic Intensive Care Setting: Recommendation for Clinical Practice | |
| TW202313111A (zh) | 治療阿茲海默症之方法 | |
| Rinaldi et al. | Radio electric asymmetric conveyer (reac) neurobiological stimulation treatments in dysfunctional motor behavior in flail arm syndrome: A case report | |
| Akter et al. | Rasmussen’s Encephalitis in Children: A Case Report | |
| Beckmann et al. | Dysphagia limit in multiple sclerosis | |
| Douma et al. | Research Article Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort | |
| JP2025084861A (ja) | 再発型の多発性硬化症を治療するための方法 | |
| Hattori et al. | A left parietooccipital lesion of 73-year-old male with right hemianopsia and sensory aphasia | |
| Vainšteine et al. | First Experience and the Effectiveness of Immunomodulating Treatment in Inflammatory Demyelinating CNS Diseases: Analysis of Nine Patients | |
| HK40107811A (zh) | 使用萨特利珠单抗治疗中枢神经系统(cns)的脱髓鞘疾病 |